Trodelvy® for the Treatment of Metastatic Urothelial Cancer
The Pharma Data
APRIL 14, 2021
A global, randomized Phase 3 confirmatory clinical trial TROPiCS-04 (NCT04527991) is underway and is also intended to support global registrations. TRODELVY contains a genotoxic component, SN-38, and targets rapidly dividing cells. More information on TROPiCS-04 is available at [link]. About Trodelvy.
52 
Let's personalize your content